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Abstract 
BACKGROUND: Lymphedema is the accumulation of a protein-rich fluid in the interstitial space due to reduced 
lymph transport capacity. Congenital primary lymphedema affecting only one of the upper limbs is a rarity. 
CASE REPORT: We present a case of an 11-month-old infant presenting with swelling of the right upper limb, 
which had gradually progressed over the past five months. Lymphoscintigraphy was suggestive of lymphatic 
blockade in the right upper limb. All other investigations were within normal limits. A diagnosis of primary 
congenital lymphedema affecting the right upper limb was made. The patient was managed conservatively with 
complex decongestive therapy and was requested regular follow-up. The lymphedema did not increase within four 
months of follow-up.  
CONCLUSIONS: Complex decongestive therapy is the cornerstone of the management of primary congenital 
lymphedema. New investigational therapies such as leukotriene B4 antagonists hold a promise for patients with 
lymphedema. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Lymphedema is a chronic localised swelling 
caused due to excessive accumulation of lymphatic 
fluid in the interstitium and resulting from defective 
lymphatic drainage [1]. Lymphedema can be primary 
or secondary. Primary lymphedema results from 
developmental abnormalities leading to pathological 
lymphatics. Secondary lymphedema is an acquired 
dysfunction of normally developed lymphatics [1] [2]. 
Congenital subtype of primary lymphedema is defined 
as swelling that has an onset at birth up to two years 
[3]. Primary congenital lymphedema affects the lower 
limbs in the majority of the cases, and unilateral 
involvement of one of the upper limbs is a rarity [4]. 
We present a case of an 11-month-old infant with 
primary congenital lymphedema affecting the right 
upper limb in isolation.  
 
 
Case report 
 
An 11-month-old infant presented to the 
department of paediatrics with a swelling of the right 
upper limb. The swelling was first noticed by the 
parents at around seven months after birth and had 
been gradually growing since then (Figures 1 and 2). 
No history of fever, trauma, pain, surgery, rash, drug 
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intake or weight loss was present. The parents of the 
patient did not have a consanguineous marriage. The 
family history of the presence of similar swellings in 
other close family members was absent. The height 
and weight of the infant were appropriate for his age. 
The general examination did not reveal any 
abnormality. Local examination of the right upper limb 
showed nonpitting, nontender oedema without any 
signs of inflammation. Radial, ulnar, and brachial 
pulses were palpable. No abnormal growth was found 
in the axillae or breasts. Generalized 
lymphadenopathy was absent. Examination of the left 
upper limb, both lower limbs, and genitalia did not 
reveal any abnormality. Routine blood and urine tests 
were within normal limits. Liver, kidney, and thyroid 
function tests were within normal ranges.  
 
Figure 1: An 11-month-old infant with unilateral lymphedema of the 
right upper limb 
 
Peripheral blood smear and antigenic testing 
for microfilariae were negative. Duplex ultrasound of 
the right upper limb, chest X-ray, HRCT of the chest 
did not reveal any abnormalities. Lymphoscintigraphy 
was suggestive of lymphatic blockade in the right 
upper limb. Based on the clinical features, and 
investigations a diagnosis of primary congenital 
lymphedema affecting the right upper limb was made.  
The patient was treated conservatively and 
was advised regular follow-up. Conservative 
management included elevation of the affected limb, 
compression bandages, and skin care. The 
lymphedema did not show any progression in the next 
four months of follow-up. 
 
Figure 2: Unilateral swelling of the right upper limb 
 
 
Discussion 
 
Primary lymphedema has an estimated 
prevalence of 1.15 per 100000 [5]. It is categorised 
according to the age of onset as congenital (before 
two years), praecox (before 35 years), and tarda (after 
35 years) [1] [2]. Isolated involvement of one of the 
upper limbs is one of the rarest forms of congenital 
lymphedema as 92 % of cases of congenital 
lymphedema involve the lower extremities [4] [6].  
Around 20 genes have been identified to be 
associated with primary lymphedema. Some of these 
genes include FLT4, VEGFR3, FOXC2, CCBE1, 
GCJ2, SOX18, GATA, and PNPN14 [7]. Genetic 
mutations explain only around one-third of the cases 
of primary lymphedema, mostly of inherited forms. 
These genes encode/regulate proteins of the vascular 
endothelial growth factor receptor-3, and other 
tyrosine kinase receptors and exert their effects via 
the RAS/MAPK and the PI3/AKT pathways [7] [8]. 
Genetic analyses for truncating the affected gene 
were not carried out in our patient due to his financial 
constraints. Some diseases such as filariasis, soft-
tissue tumours, Kippel-Trenaunay syndrome, and 
chronic venous insufficiency mimic isolated primary 
lymphedema of the upper limb. In each of these 
conditions, the swelling progresses gradually and 
painlessly over a period of weeks or months [9]. Each 
of these conditions were systematically ruled out in 
our patient through the clinical history, examination, 
and appropriate investigations.  
Management of primary lymphedema is done 
via decongestive lymphatic therapy, which includes an 
intensive and maintenance phase. Both these phases 
include the use of compression bandages, therapeutic 
exercises, skin care, manual lymphatic drainage, and 
patient education [10]. Our patient did not show any 
increase in lymphedema after undergoing a month of 
intensive and three months of maintenance 
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decongestive therapy. However, the parents of the 
child were advised monthly follow-ups and look out for 
an increase in the size of the swelling, signs of 
inflammation, hyperkeratotic skin lesions, and 
verrucous growths.  
Currently, there is no effective 
pharmacotherapy for primary lymphedema. Short-
term administration of diuretics is found to be effective 
in some patients in the initial stages of lymphedema. 
Long-term administration of benzopyrones increases 
hydrolysis and absorption of tissue proteins at the site 
of lymphedema. Intra-arterial autologous lymphocyte 
injection is suggested to enhances the proteolysis of 
extracellular proteins and reduce lymphedema in 
some reports. Zinc supplementation and low-fat diet 
were found to effective in reducing lymphedema in a 
few reports. Use of propranolol has been suggested to 
improve some symptoms of lymphedema in a report. 
Surgical interventions such as debulking procedures, 
resection approach, buried-dermal flaps, microsurgical 
techniques, and liposuction are rarely indicated due to 
their low success rates. Surgical therapy is usually 
tried only when conservative management has failed 
[1] [11].  
Preclinical evidence suggests that exogenous 
injection of human recombinant vascular endothelial 
growth factor C restores lymphatic flow. Also, 
adipose-derived stem cells have shown potential in 
lymphedema therapy [12]. Drugs targeting the 
PI3/AKT/mTOR signalling pathway such as 
mechanistic target of rapamycin inhibitors are also 
being evaluated for reducing lymphedema in some 
somatic overgrowth disorders [2]. Leukotriene B4 
affects lymphangiogenesis in animal models and is 
elevated in patients with lymphedema. Hence, drugs 
antagonising the effect of leukotriene B4 such as 
ketoprofen, and bestatin are presently being 
evaluated in Phase-2 of clinical trials [13]. 
In conclusion, primary congenital 
lymphedema affecting only one of the upper limbs is 
an extremely rare disorder. Conservative 
management via decongestive therapy prevented 
further progression of the lymphedema in our patient. 
Investigational therapeutic agents such as leukotriene 
B4 antagonists provide an exciting prospect for 
patients with lymphedema.  
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